6-Iodo-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
95%
- Product Code: 53827
CAS:
773865-48-8
| Molecular Weight: | 329.1000 g./mol | Molecular Formula: | C₁₁H₈INO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06009652 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various quinoline derivatives, which are known for their broad spectrum of biological activities. Specifically, it is used in the development of antibacterial and antimicrobial agents, owing to the structural features of the quinoline core that enhance binding to bacterial enzymes and proteins. Additionally, its iodine substituent makes it a valuable precursor for further chemical modifications, enabling the creation of compounds with potential therapeutic applications. Researchers also explore its use in designing drugs targeting specific bacterial infections, leveraging its ability to inhibit bacterial DNA gyrase and topoisomerase IV.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿3,348.00 |
+
-
|
6-Iodo-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various quinoline derivatives, which are known for their broad spectrum of biological activities. Specifically, it is used in the development of antibacterial and antimicrobial agents, owing to the structural features of the quinoline core that enhance binding to bacterial enzymes and proteins. Additionally, its iodine substituent makes it a valuable precursor for further chemical modifications, enabling the creation of compounds with potential therapeutic applications. Researchers also explore its use in designing drugs targeting specific bacterial infections, leveraging its ability to inhibit bacterial DNA gyrase and topoisomerase IV.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :